High Content Cellular Imaging & Image Cytometry Symposium Oct 11, 2012
60 views
Skip to first unread message
Joe Trask
unread,
Sep 25, 2012, 11:06:11 AM9/25/12
Reply to author
Sign in to reply to author
Forward
Sign in to forward
Delete
You do not have permission to delete messages in this group
Copy link
Report message
Show original message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to highc...@googlegroups.com
The Society of Biomolecular Imaging and Informatics (SBI2) and Research Triangle Cytometry Association (RTCA) Presents the 3rd High Content Cellular Imaging & Image Cytometry Symposium on Thursday, October 11, 2012 at the North Carolina Biotechnology Center, 15 T.W. Alexander Drive, Research Triangle Park, North Carolina
08:00 – 08:30 Registration; Coffee and light breakfast
08:30 – 09:00 Opening Remarks, Introduction, and “Why SBI2?” Joe Trask, Head of Cellular Imaging Core, The Hamner Institutes for Health Sciences & President of SBI2
09:00 – 10:00 Keynote Address: “A Historical Perspective of Image Analysis” by John Russ, Ph.D., North Carolina State University.
10:00 – 10:30 Technology Spotlight-I: Yokogawa CV7000 Confocal HCS Imager, Rob Bukar, Director of Business Development, Wako Automation
10:30 – 10:45 Break, 15 minutes
10:45 – 11:30 “Development and Implementation of an AR-GFP nuclear localization HCS on the ImageXpress Ultra Platform to identify compounds with potential for prostate cancer therapy", Paul Johnston, Ph.D., Research Associate Professor, President-Elect SBI2 , University of Pittsburgh, Department of Pharmaceutical Sciences. Molelar Devices Corporation, Tim Baranowski, Ph.D., Field Application Scientist – Imaging
11:30 – 12:15 “Linking chromatin organization and function in the mammalian cell nucleus: the combined power of high-throughput microscopy and biochemical methods” Ty Voss, Ph.D., Facility ead, NCI High-Throughput Imaging Facility, Laboratory of Receptor Biology & Gene Expression, National Cancer Institute. Perkin Elmer, Aaron Risinger, High Content Screening Sales Specialist, North American Product Line Leader, PerkinElmer High Content Screening
12:15 – 1:30 Lunch & Networking
1:30 – 2:15 “Maximizing Small Scale Drug Discovery for High Impact”, Justin D. Boyd, Ph.D., Scientist, Laboratory of Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Harvard Medical School & Brigham and Women's Hospital GE HealthCare, Robert Graves, Ph.D., Senior Applications Scientist
2:15 – 3:00 “High-Throughput and High-Content Imaging in the Tox21 program”, Bonnie Goodwin, Ph.D., Research Scientist, National Center for Advancing Translational Sciences, NIH Thermo Scientific (Cellomics), Scott Keefer, MBA, Product Management, Life Science Research 3:00 – 3:30 "Standards, Science and Software - A personal reflection on a decade of high content informatics", Mark Collins, Ph.D., CEO, PurpleBio Consulting, Treasurer of SBI2.
3:30 – 3:45 Break, 15 minutes
3:45 – 4:30 Technology Spotlight-II: “Integrating Data Mining with Image Analysis in High Content Cellular Imaging”, Alan Jerusalmi, Ph.D., Senior Consultant, Definiens
4:30 – 4:45 “Resources for the High Content Analysis/Imaging/Screening Community” Steve Haney, Ph.D., Sr. Research Adviser, Quantitative Biology, and Group Leader, Oncology Drug Discovery, Eli Lilly and Company, Secretary of SBI2
4:45 - 5:30 “New Chapters from The Molecular Probes®Handbook: Labeling and Detection Strategies in Fluorescence Microscopy”, Daniel Beacham, Ph.D., Senior Staff Scientist, Cellular Imaging & Analysis, Life Technologies 5:30 – 5:35 Closing remarks
5:35 – 7:30 Reception, sponsored by Life Technologies (please register if attending)